Keywords: Cardiovascular, Cardiomyopathy
Motivation: Duchenne muscular dystrophy (DMD) leads to pediatric cardiomyopathy. Pre-contrast T1 in DMD identifies myocardial remodeling, but it remains unclear if T1-Mapping biomarkers can detect longitudinal changes in DMD.
Goal(s): The objective was to characterize progressive myocardial pre-contrast T1 changes in DMD at 3T.
Approach: Boys with DMD and healthy controls underwent a 3T CMR exam that included standard functional and pre-contrast T1 mapping sequences. Boys with DMD were examined at two points (18 months apart).
Results: Pre-contrast T1 was capable of detecting progressive changes in boys with DMD 18 months post baseline while functional metrics like LVEF did not.
Impact: T1 Mapping biomarkers can detect disease progression in DMD. T1 Mapping biomarkers, in combination with biomarkers of function have the potential to track patient-specific changes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords